Cargando…

Profiling Differential Effects of 5 Selective Serotonin Reuptake Inhibitors on TLRs-Dependent and -Independent IL-6 Production in Immune Cells Identifies Fluoxetine as Preferred Anti-Inflammatory Drug Candidate

Excessive proinflammatory cytokine production induced by abnormal activation of Toll-like receptor (TLR) signaling, for example, by SARS-CoV-2 infection, can cause a fatal cytokine storm. The selective serotonin reuptake inhibitors (SSRIs) fluoxetine and fluvoxamine, used to treat depression, were r...

Descripción completa

Detalles Bibliográficos
Autores principales: Takenaka, Yohei, Tanaka, Ryu, Kitabatake, Kazuki, Kuramochi, Kouji, Aoki, Shin, Tsukimoto, Mitsutoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9257214/
https://www.ncbi.nlm.nih.gov/pubmed/35814203
http://dx.doi.org/10.3389/fphar.2022.874375
_version_ 1784741294537441280
author Takenaka, Yohei
Tanaka, Ryu
Kitabatake, Kazuki
Kuramochi, Kouji
Aoki, Shin
Tsukimoto, Mitsutoshi
author_facet Takenaka, Yohei
Tanaka, Ryu
Kitabatake, Kazuki
Kuramochi, Kouji
Aoki, Shin
Tsukimoto, Mitsutoshi
author_sort Takenaka, Yohei
collection PubMed
description Excessive proinflammatory cytokine production induced by abnormal activation of Toll-like receptor (TLR) signaling, for example, by SARS-CoV-2 infection, can cause a fatal cytokine storm. The selective serotonin reuptake inhibitors (SSRIs) fluoxetine and fluvoxamine, used to treat depression, were recently reported to reduce the risk of severe disease in patients with coronavirus disease 2019 (COVID-19), but the mechanisms of the anti-inflammatory effects of SSRIs, and which SSRI would be most suitable as an anti-inflammatory drug, remain unclear. Here, we examined the inhibitory effects of 5 FDA-approved SSRIs, paroxetine, fluoxetine, fluvoxamine, sertraline and escitalopram, on the production of interleukin-6 (IL-6) induced by stimulation with multiple TLR agonists in murine macrophages and dendritic cells, and on the production of cytokines induced by concanavalin A in murine lymphocytes. In J774.1 murine macrophage cells, pretreatment with SSRIs significantly suppressed IL-6 release induced by TLR3 agonist poly(I:C), TLR4 agonist LPS or TLR9 agonist CpG ODN, but did not affect IL-6 release induced by TLR7 agonists imiquimod or resiquimod. In accordance with the results obtained in J774.1 cells, pretreatment with SSRIs also suppressed IL-6 release induced by a TLR3, TLR4 or TLR9 agonist in bone marrow-derived dendritic cells and peritoneal cells of C57BL/6 mice. On the other hand, interestingly, sertraline alone among the SSRIs amplified IL-6 production induced by TLR7 agonists in murine dendritic cells, though not in macrophages. Concanavalin A-induced production of IL-6 or IL-2 in murine lymphocytes was suppressed by SSRIs, suggesting that SSRIs also inhibit TLRs-independent IL-6 production. Since SSRIs suppressed both IL-6 production induced by multiple TLR agonists in macrophages or dendritic cells and TLR-independent IL-6 production in lymphocytes, they are promising candidates for treatment of patients with cytokine storm, which is mediated by overactivation of multiple TLRs in a complex manner, leading to the so-called IL-6 amplifier, an IL-6 overproduction loop. However, the 5 SSRIs examined here all showed different effects. Overall, our results suggest that fluoxetine may be the most promising candidate as an anti-inflammatory drug. An examination of the structural requirements indicated that the N-methyl group of fluoxetine has a critical role in the inhibition of IL-6 production.
format Online
Article
Text
id pubmed-9257214
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-92572142022-07-07 Profiling Differential Effects of 5 Selective Serotonin Reuptake Inhibitors on TLRs-Dependent and -Independent IL-6 Production in Immune Cells Identifies Fluoxetine as Preferred Anti-Inflammatory Drug Candidate Takenaka, Yohei Tanaka, Ryu Kitabatake, Kazuki Kuramochi, Kouji Aoki, Shin Tsukimoto, Mitsutoshi Front Pharmacol Pharmacology Excessive proinflammatory cytokine production induced by abnormal activation of Toll-like receptor (TLR) signaling, for example, by SARS-CoV-2 infection, can cause a fatal cytokine storm. The selective serotonin reuptake inhibitors (SSRIs) fluoxetine and fluvoxamine, used to treat depression, were recently reported to reduce the risk of severe disease in patients with coronavirus disease 2019 (COVID-19), but the mechanisms of the anti-inflammatory effects of SSRIs, and which SSRI would be most suitable as an anti-inflammatory drug, remain unclear. Here, we examined the inhibitory effects of 5 FDA-approved SSRIs, paroxetine, fluoxetine, fluvoxamine, sertraline and escitalopram, on the production of interleukin-6 (IL-6) induced by stimulation with multiple TLR agonists in murine macrophages and dendritic cells, and on the production of cytokines induced by concanavalin A in murine lymphocytes. In J774.1 murine macrophage cells, pretreatment with SSRIs significantly suppressed IL-6 release induced by TLR3 agonist poly(I:C), TLR4 agonist LPS or TLR9 agonist CpG ODN, but did not affect IL-6 release induced by TLR7 agonists imiquimod or resiquimod. In accordance with the results obtained in J774.1 cells, pretreatment with SSRIs also suppressed IL-6 release induced by a TLR3, TLR4 or TLR9 agonist in bone marrow-derived dendritic cells and peritoneal cells of C57BL/6 mice. On the other hand, interestingly, sertraline alone among the SSRIs amplified IL-6 production induced by TLR7 agonists in murine dendritic cells, though not in macrophages. Concanavalin A-induced production of IL-6 or IL-2 in murine lymphocytes was suppressed by SSRIs, suggesting that SSRIs also inhibit TLRs-independent IL-6 production. Since SSRIs suppressed both IL-6 production induced by multiple TLR agonists in macrophages or dendritic cells and TLR-independent IL-6 production in lymphocytes, they are promising candidates for treatment of patients with cytokine storm, which is mediated by overactivation of multiple TLRs in a complex manner, leading to the so-called IL-6 amplifier, an IL-6 overproduction loop. However, the 5 SSRIs examined here all showed different effects. Overall, our results suggest that fluoxetine may be the most promising candidate as an anti-inflammatory drug. An examination of the structural requirements indicated that the N-methyl group of fluoxetine has a critical role in the inhibition of IL-6 production. Frontiers Media S.A. 2022-06-22 /pmc/articles/PMC9257214/ /pubmed/35814203 http://dx.doi.org/10.3389/fphar.2022.874375 Text en Copyright © 2022 Takenaka, Tanaka, Kitabatake, Kuramochi, Aoki and Tsukimoto. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Takenaka, Yohei
Tanaka, Ryu
Kitabatake, Kazuki
Kuramochi, Kouji
Aoki, Shin
Tsukimoto, Mitsutoshi
Profiling Differential Effects of 5 Selective Serotonin Reuptake Inhibitors on TLRs-Dependent and -Independent IL-6 Production in Immune Cells Identifies Fluoxetine as Preferred Anti-Inflammatory Drug Candidate
title Profiling Differential Effects of 5 Selective Serotonin Reuptake Inhibitors on TLRs-Dependent and -Independent IL-6 Production in Immune Cells Identifies Fluoxetine as Preferred Anti-Inflammatory Drug Candidate
title_full Profiling Differential Effects of 5 Selective Serotonin Reuptake Inhibitors on TLRs-Dependent and -Independent IL-6 Production in Immune Cells Identifies Fluoxetine as Preferred Anti-Inflammatory Drug Candidate
title_fullStr Profiling Differential Effects of 5 Selective Serotonin Reuptake Inhibitors on TLRs-Dependent and -Independent IL-6 Production in Immune Cells Identifies Fluoxetine as Preferred Anti-Inflammatory Drug Candidate
title_full_unstemmed Profiling Differential Effects of 5 Selective Serotonin Reuptake Inhibitors on TLRs-Dependent and -Independent IL-6 Production in Immune Cells Identifies Fluoxetine as Preferred Anti-Inflammatory Drug Candidate
title_short Profiling Differential Effects of 5 Selective Serotonin Reuptake Inhibitors on TLRs-Dependent and -Independent IL-6 Production in Immune Cells Identifies Fluoxetine as Preferred Anti-Inflammatory Drug Candidate
title_sort profiling differential effects of 5 selective serotonin reuptake inhibitors on tlrs-dependent and -independent il-6 production in immune cells identifies fluoxetine as preferred anti-inflammatory drug candidate
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9257214/
https://www.ncbi.nlm.nih.gov/pubmed/35814203
http://dx.doi.org/10.3389/fphar.2022.874375
work_keys_str_mv AT takenakayohei profilingdifferentialeffectsof5selectiveserotoninreuptakeinhibitorsontlrsdependentandindependentil6productioninimmunecellsidentifiesfluoxetineaspreferredantiinflammatorydrugcandidate
AT tanakaryu profilingdifferentialeffectsof5selectiveserotoninreuptakeinhibitorsontlrsdependentandindependentil6productioninimmunecellsidentifiesfluoxetineaspreferredantiinflammatorydrugcandidate
AT kitabatakekazuki profilingdifferentialeffectsof5selectiveserotoninreuptakeinhibitorsontlrsdependentandindependentil6productioninimmunecellsidentifiesfluoxetineaspreferredantiinflammatorydrugcandidate
AT kuramochikouji profilingdifferentialeffectsof5selectiveserotoninreuptakeinhibitorsontlrsdependentandindependentil6productioninimmunecellsidentifiesfluoxetineaspreferredantiinflammatorydrugcandidate
AT aokishin profilingdifferentialeffectsof5selectiveserotoninreuptakeinhibitorsontlrsdependentandindependentil6productioninimmunecellsidentifiesfluoxetineaspreferredantiinflammatorydrugcandidate
AT tsukimotomitsutoshi profilingdifferentialeffectsof5selectiveserotoninreuptakeinhibitorsontlrsdependentandindependentil6productioninimmunecellsidentifiesfluoxetineaspreferredantiinflammatorydrugcandidate